155 related articles for article (PubMed ID: 9294507)
1. Combination assay for tumor markers in oral squamous cell carcinoma.
Kurokawa H; Yamashita Y; Tokudome S; Kajiyama M
J Oral Maxillofac Surg; 1997 Sep; 55(9):964-6. PubMed ID: 9294507
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of tumor markers in patients with squamous cell carcinoma in the oral cavity.
Kurokawa H; Tsuru S; Okada M; Nakamura T; Kajiyama M
Int J Oral Maxillofac Surg; 1993 Feb; 22(1):35-8. PubMed ID: 7681461
[TBL] [Abstract][Full Text] [Related]
3. CYFRA 21-1 enzyme-linked immunosorbent assay. Evaluation as a tumor marker in non-small cell lung cancer.
Lai RS; Hsu HK; Lu JY; Ger LP; Lai NS
Chest; 1996 Apr; 109(4):995-1000. PubMed ID: 8635383
[TBL] [Abstract][Full Text] [Related]
4. Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer.
Tas F; Aydiner A; Topuz E; Yasasever V; Karadeniz A; Saip P
J Exp Clin Cancer Res; 2000 Dec; 19(4):477-81. PubMed ID: 11277326
[TBL] [Abstract][Full Text] [Related]
5. Serum SCCA, Cyfra 21-1, EGFR and Cyclin D1 levels in patients with oral squamous cell carcinoma.
Feng XY; Li JH; Li JZ; Han ZX; Xing RD
Int J Biol Markers; 2010; 25(2):93-8. PubMed ID: 20586028
[TBL] [Abstract][Full Text] [Related]
6. CYFRA 21-1 is a useful marker for esophageal squamous cell carcinoma.
Yamamoto K; Oka M; Hayashi H; Tangoku A; Gondo T; Suzuki T
Cancer; 1997 May; 79(9):1647-55. PubMed ID: 9128978
[TBL] [Abstract][Full Text] [Related]
7. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck.
Inal E; Laçin M; Asal K; Ceylan A; Köybaşioğlu A; Ileri F; Uslu SS
Kulak Burun Bogaz Ihtis Derg; 2004; 12(1-2):23-30. PubMed ID: 16010093
[TBL] [Abstract][Full Text] [Related]
8. Comparison of tumor markers in patients with squamous cell carcinoma of the head and neck.
Ogawa T; Tsurusako Y; Kimura N; Nishioka S; Akagi H; Nishizaki K; Nishioka K; Rutka J
Acta Otolaryngol Suppl; 1999; 540():72-6. PubMed ID: 10445084
[TBL] [Abstract][Full Text] [Related]
9. High levels of cytokeratin 19 fragments but no evidence of cytokeratins 1, 2, 10/11, 14 or filaggrin in the serum of squamous cell lung carcinoma patients.
Miédougé M; Devys A; Simon M; Rouzaud P; Salama G; Reyre J; Pujazon M; Carles P; Serre G
Tumour Biol; 2001; 22(1):19-26. PubMed ID: 11054023
[TBL] [Abstract][Full Text] [Related]
10. [CYFRA 21-1: a new marker of epidermoid cancer of the bronchi. Comparison with 3 other markers].
Pujol JL; Grenier J; Ray P; Gautier V; Aouta MD; Michel FB
Presse Med; 1993 Jun; 22(22):1039-42. PubMed ID: 7692432
[TBL] [Abstract][Full Text] [Related]
11. SCCA, TSGF, and the Long Non-Coding RNA AC007271.3 are Effective Biomarkers for Diagnosing Oral Squamous Cell Carcinoma.
Shao T; Huang J; Zheng Z; Wu Q; Liu T; Lv X
Cell Physiol Biochem; 2018; 47(1):26-38. PubMed ID: 29763905
[TBL] [Abstract][Full Text] [Related]
12. Prognosis in bronchogenic squamous cell carcinoma groups divided according to serum squamous cell carcinoma-related antigen and cytokeratin 19 fragment levels.
Kashiwabara K; Nakamura H; Esaki T
Clin Chim Acta; 2000 Apr; 294(1-2):105-13. PubMed ID: 10727677
[TBL] [Abstract][Full Text] [Related]
13. A study of a new tumour marker, CYFRA 21-1, in squamous cell carcinoma of the head and neck, and comparison with squamous cell carcinoma antigen.
Yen TC; Lin WY; Kao CH; Cheng KY; Wang SJ
Clin Otolaryngol Allied Sci; 1998 Feb; 23(1):82-6. PubMed ID: 9563673
[TBL] [Abstract][Full Text] [Related]
14. Clinical value of serum HMGB1 levels in early detection of recurrent squamous cell carcinoma of uterine cervix: comparison with serum SCCA, CYFRA21-1, and CEA levels.
Sheng X; Du X; Zhang X; Li D; Lu C; Li Q; Ma Z; Song Q; Wang C
Croat Med J; 2009 Oct; 50(5):455-64. PubMed ID: 19839069
[TBL] [Abstract][Full Text] [Related]
15. Assessment of serum CYFRA 21-1 in lung cancer.
Muraki M; Tohda Y; Iwanaga T; Uejima H; Nagasaka Y; Nakajima S
Cancer; 1996 Apr; 77(7):1274-7. PubMed ID: 8608502
[TBL] [Abstract][Full Text] [Related]
16. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.
Ando S; Kimura H; Iwai N; Shima M; Ando M; Kuriyama T
Anticancer Res; 2001; 21(4B):3085-92. PubMed ID: 11712815
[TBL] [Abstract][Full Text] [Related]
17. [Usefulness of the SCC, CEA, CYFRA 21.1, and CRP markers for the diagnosis and monitoring of cervical squamous cell carcinoma].
Chmura A; Wojcieszek A; Mrochem J; Walaszek-Gruszka A; Deja R; Masłyk B; Bartnik W; Sodowski K
Ginekol Pol; 2009 May; 80(5):361-6. PubMed ID: 19548456
[TBL] [Abstract][Full Text] [Related]
18. Prospective study of a panel of tumor markers as prognostic factors in patients with squamous cell carcinoma of head and neck.
Kandiloros D; Eleftheriadou A; Chalastras T; Kyriou L; Yiotakis I; Ferekidis E
Med Oncol; 2006; 23(4):463-70. PubMed ID: 17303904
[TBL] [Abstract][Full Text] [Related]
19. Comparison of CYFRA 21-1 and squamous cell carcinoma antigen in detecting nasopharyngeal carcinoma.
Lee JK; Hsieh JF; Tsai SC; Ho YJ; Sun SS; Kao CH
Ann Otol Rhinol Laryngol; 2001 Aug; 110(8):775-8. PubMed ID: 11510737
[TBL] [Abstract][Full Text] [Related]
20. Cytokeratin subunit 19 measured by CYFRA 21-1 assay in follow-up of cervical cancer.
Kainz C; Sliutz G; Mustafa G; Bieglmayr C; Koelbl H; Reinthaller A; Gitsch G
Gynecol Oncol; 1995 Mar; 56(3):402-5. PubMed ID: 7535720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
